Research Library

Peptide Research & Insights

Evidence-based articles on peptide mechanisms, research findings and practical context — written to answer the questions researchers actually ask.

78Articles
0Topics
Sep 2026Last updated
SourcedCited research
Showing 78
Sermorelin Anti-Aging: What Studies Measured (2026) Anti-Aging

Sermorelin Anti-Aging: What Studies Measured (2026)

Sermorelin research demonstrates its ability to enhance endogenous growth hormone secretion, support muscle regeneration, and improve metabolic homeostasis in aging models. Studies...

Dec 4, 2025 · 12 min read
Glow Peptide Side Effects & Safety (2026) Skin Support

Glow Peptide Side Effects & Safety (2026)

Glow peptide research examines how its component peptides influence ageing and pigmentation pathways through defined molecular mechanisms. Studies report measurable shifts in...

Nov 27, 2025 · 6 min read
Orforglipron Results by Dose: Trial Chart (2026) Fat Loss

Orforglipron Results by Dose: Trial Chart (2026)

This blog offers a research-focused overview of Orforglipron’s metabolic effects derived from controlled studies. It examines weight outcomes, lipid profiles, glycemic markers,...

Nov 23, 2025 · 11 min read
KLOW Peptide: No Clinical Trials on the Blend (2026) Skin Support

KLOW Peptide: No Clinical Trials on the Blend (2026)

Klow is evaluated through controlled preclinical research that examines collagen structure, elasticity markers, and peptide-driven cellular responses. These studies explore how its...

Nov 20, 2025 · 6 min read
Melanotan 1 vs 2: Tanning, Side Effects (2026) Skin Support

Melanotan 1 vs 2: Tanning, Side Effects (2026)

Melanotan II is widely studied for its role in regulating melanin pathways through controlled laboratory investigations. Researchers examine its receptor interactions, signalling...

Nov 20, 2025 · 12 min read
GHK-Cu Benefits: Topical vs Injected Evidence (2026) Skin Support

GHK-Cu Benefits: Topical vs Injected Evidence (2026)

This blog explores how GHK-Cu functions in collagen pathways, wrinkle-related studies, and skin-matrix research. It highlights key molecular mechanisms supported by university-backed...

Nov 20, 2025 · 10 min read
Retatrutide Results: Weight Loss by Dose (2026) Fat Loss

Retatrutide Results: Weight Loss by Dose (2026)

Retatrutide demonstrates strong research-driven effects on obesity-related metabolic pathways, showcasing meaningful changes in adiposity, lipid profiles, and insulin sensitivity. Its triagonist mechanism...

Nov 17, 2025 · 13 min read
TB-500 for Tendon Repair: Results & Evidence (2026) Muscle Growth

TB-500 for Tendon Repair: Results & Evidence (2026)

This blog examines current preclinical evidence on TB-500 and its role in tendon and ligament research. It highlights cellular pathways, comparative peptide...

Nov 17, 2025 · 11 min read
GLP-1 and Arterial Stiffness Explained (2026) Anti-Aging

GLP-1 and Arterial Stiffness Explained (2026)

This blog explores the scientific evaluation of GLP-1 signaling and its mechanistic link to arterial stiffness regulation. It highlights how GLP-1 receptor...

Nov 3, 2025 · 5 min read
AOD-9604 Side Effects: What the Trials Show (2026) Cognitive Support

AOD-9604 Side Effects: What the Trials Show (2026)

This research-focused article examines how AOD 9604 interacts with metabolic and inflammatory pathways linked to obesity-related cognitive decline. It highlights preclinical evidence...

Oct 31, 2025 · 9 min read
KLOW Peptide Studies: What the Evidence Shows (2026) Muscle Growth

KLOW Peptide Studies: What the Evidence Shows (2026)

This blog examines the scientific basis of KLOW peptides, concentrating on their molecular mechanisms in angiogenesis, inflammation regulation, and tissue regeneration. It...

Oct 23, 2025 · 6 min read
GLP-1 and Lipids: What the Research Shows (2026) Fat Loss

GLP-1 and Lipids: What the Research Shows (2026)

This blog explores how GLP-1 pathways regulate lipid metabolism in atherogenic dyslipidemia through mechanisms involving hepatic oxidation, cholesterol efflux, and lipoprotein modulation....

Oct 22, 2025 · 5 min read
AOD-9604 for Cartilage and Joint Repair (2026) Fat Loss

AOD-9604 for Cartilage and Joint Repair (2026)

AOD-9604 is a synthetic peptide investigated for its potential role in metabolic regulation and tissue regeneration under experimental conditions. According to preclinical...

Oct 19, 2025 · 6 min read
Cagrilintide Kidney Side Effects & Safety (2026) Fat Loss

Cagrilintide Kidney Side Effects & Safety (2026)

Cagrilintide shows promising results for patients with chronic kidney disease (CKD), offering safe and effective weight management, improved glycemic control, and potential...

Oct 12, 2025 · 11 min read
TB-500 and Fibrosis: Scar Tissue Explained (2026) Muscle Growth

TB-500 and Fibrosis: Scar Tissue Explained (2026)

TB-500, a synthetic peptide, shows promising preclinical evidence in promoting tissue repair and reducing fibrosis in lung injury models. Its role in...

Sep 29, 2025 · 10 min read
NAD+ vs NMN: Key Differences Explained (2026) Anti-Aging

NAD+ vs NMN: Key Differences Explained (2026)

NAD+ is vital for energy metabolism, DNA repair, and cellular health, directly shaping the aging process. Its decline accelerates cellular dysfunction and...

Sep 22, 2025 · 14 min read
How Cagrilintide Works: Timeline & Results (2026) Fat Loss

How Cagrilintide Works: Timeline & Results (2026)

Cagrilintide, a next-generation amylin analog peptide, offers promising advances in obesity treatment by targeting brain hunger pathways. This blog explores its unique...

Sep 13, 2025 · 12 min read
Semaglutide vs Tirzepatide vs Retatrutide (2026) benefits of peptides

Semaglutide vs Tirzepatide vs Retatrutide (2026)

Semaglutide, a powerful GLP-1 receptor agonist, revolutionizes diabetes and obesity treatment by reducing appetite, enhancing insulin secretion, and slowing gastric emptying. Clinical...

Sep 7, 2025 · 13 min read
Retatrutide vs Tirzepatide: Trial Results (2026) Fat Loss

Retatrutide vs Tirzepatide: Trial Results (2026)

Retatrutide is an innovative triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, offering a promising approach for obesity and type 2...

Sep 7, 2025 · 15 min read
Is Tirzepatide a GLP-1? What GIP Adds (2026) Benefits of Tirzepatide

Is Tirzepatide a GLP-1? What GIP Adds (2026)

Tirzepatide, a dual GIP/GLP-1 receptor agonist, helps regulate blood sugar and appetite, supporting weight loss, improved insulin sensitivity, and metabolic health. Prime...

Sep 7, 2025 · 11 min read